NCT02622685 - A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Healthy

Interventions

DRUG

DWP10292

Drug: DWP10292 tablets, oral administration, multiple administration

DRUG

DWP10292 Placebo

Placebo tablets, oral administration, multiple administrations

DRUG

Ursodeoxycholic acid (UDCA)

Drug: Ursodeoxycholic acid (UDCA) tablets, oral administration, multiple administration

DRUG

UDCA Placebo

Placebo tablets, oral administration, multiple administrations